Effect of encouraging people with non-communicable diseases to receive medical consultation based on medical data

Effect of encouraging people with non-communicable diseases to receive medical consultation based on medical data - Effect of encouraging people with non-communicable diseases to receive medical consultation

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000049315

Enrollment

300

Registered

2022-11-01

Start date

2022-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypertension, dyslipidemia, diabetes mellitus

Interventions

Intervention group Clustering of factors related to medical consultation behavior based on medical data, and sending of medical consultation notifications appropriate to the appeal points according

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Insured persons in the Health Insurance Association 1. Persons who meet any of the following criteria based on the results of the medical checkup - Blood pressure: Systolic blood pressure 160 mmHg or higher and/or diastolic blood pressure 100 mmHg or higher - Lipid: Low-Density Lipoprotein (LDL) cholesterol level 180 mg/dL or higher and/or High-Density Lipoprotein (HDL) cholesterol level 30 mg/dL or lower and/or triglycerides 500 mg/dL or higher - Blood glucose: Fasting blood glucose 140 mg/dL or higher and/or Hemoglobin A1c (HbA1c) 7.0% or higher 2. Those who have no medical history of the target disease

Exclusion criteria

Exclusion criteria: Those who refused to participate in the study

Design outcomes

Primary

Measure	Time frame
Proportion of patients who receive treatment and retained treatment	—

Secondary

Measure	Time frame
Disease management status for non-communicable diseases	—

Countries

Japan

Contacts

Public ContactKento Takeyama

PREVENT inc. Department of Business Planning

business_planning@prevent.co.jp052-715-7955

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026